Brandhorst G - Search Results

1

Confronting the challenge: individualized immune monitoring after organ transplantation using the cellular immune function assay.

Israeli M, Klein T, Brandhorst G, Oellerich M. Israeli M, et al. Among authors: brandhorst g. Clin Chim Acta. 2012 Sep 8;413(17-18):1374-8. doi: 10.1016/j.cca.2012.01.033. Epub 2012 Feb 3. Clin Chim Acta. 2012. PMID: 22333671 Review.

2

CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.

Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD. Brandhorst G, et al. Clin Chim Acta. 2013 Jun 5;421:31-3. doi: 10.1016/j.cca.2013.02.016. Epub 2013 Feb 26. Clin Chim Acta. 2013. PMID: 23485644

3

Individually tailored immunosuppression: is there a role for biomarkers?

Brandhorst G, Oellerich M, Brunet M, Kowalski R, Vinks A, Wallemacq P. Brandhorst G, et al. Clin Chem. 2011 Mar;57(3):376-81. doi: 10.1373/clinchem.2010.159871. Epub 2011 Jan 12. Clin Chem. 2011. PMID: 21228253 No abstract available.

4

Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring?

Brandhorst G, Oellerich M, Maine G, Taylor P, Veen G, Wallemacq P. Brandhorst G, et al. Clin Chem. 2012 May;58(5):821-5. doi: 10.1373/clinchem.2011.167189. Epub 2012 Jan 17. Clin Chem. 2012. PMID: 22252324 No abstract available.

5

Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites.

Brandhorst G, Streit F, Goetze S, Oellerich M, Armstrong VW. Brandhorst G, et al. Clin Chem. 2006 Oct;52(10):1962-4. doi: 10.1373/clinchem.2006.074336. Epub 2006 Aug 24. Clin Chem. 2006. PMID: 16931568

6

Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.

Schulz-Juergensen S, Burdelski MM, Oellerich M, Brandhorst G. Schulz-Juergensen S, et al. Among authors: brandhorst g. Ther Drug Monit. 2012 Feb;34(1):4-10. doi: 10.1097/FTD.0b013e31823c5668. Ther Drug Monit. 2012. PMID: 22210096

7

Therapeutic drug monitoring and drugs of abuse testing on the cobas 6000 analyzer series: analytical performance under routine-like conditions.

Brandhorst G, Luthe H, Domke I, Knoke C, Rhode KH, Sauter H, Oellerich M. Brandhorst G, et al. Clin Chem Lab Med. 2009;47(7):854-9. doi: 10.1515/CCLM.2009.191. Clin Chem Lab Med. 2009. PMID: 19496737

8

Pre-analytical effects of different lithium heparin plasma separation tubes in the routine clinical chemistry laboratory.

Brandhorst G, Engelmayer J, Götze S, Oellerich M, von Ahsen N. Brandhorst G, et al. Clin Chem Lab Med. 2011 Sep;49(9):1473-7. doi: 10.1515/CCLM.2011.606. Epub 2011 May 24. Clin Chem Lab Med. 2011. PMID: 21605014

9

Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.

Shipkova M, Petrova DT, Rosler AE, Orth M, Engelmayer J, Wieland E, Brandhorst G, Oellerich M. Shipkova M, et al. Among authors: brandhorst g. Ther Drug Monit. 2014 Aug;36(4):433-41. doi: 10.1097/FTD.0000000000000043. Ther Drug Monit. 2014. PMID: 24646729

10

Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.

Brandhorst G, Tenderich G, Zittermann A, Oezpeker C, Koerfer R, Oellerich M, Armstrong VW. Brandhorst G, et al. Ther Drug Monit. 2008 Feb;30(1):113-6. doi: 10.1097/FTD.0b013e318161a335. Ther Drug Monit. 2008. PMID: 18223473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters